Pete Stavropoulos
Stock Analyst at Cantor Fitzgerald
(4.18)
# 460
Out of 4,479 analysts
28
Total ratings
44.83%
Success rate
19.65%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Initiates: Overweight | n/a | $26.27 | - | 1 | Jun 27, 2024 | |
| JSPR Jasper Therapeutics | Reiterates: Overweight | n/a | $22.78 | - | 4 | Jun 18, 2024 | |
| ANNX Annexon | Reiterates: Overweight | n/a | $4.57 | - | 8 | Jun 5, 2024 | |
| ALEC Alector | Reiterates: Overweight | n/a | $4.34 | - | 2 | May 9, 2024 | |
| VERA Vera Therapeutics | Initiates: Overweight | n/a | $34.93 | - | 1 | Jan 8, 2024 | |
| RZLT Rezolute | Reiterates: Overweight | $5 | $4.21 | +18.76% | 3 | Sep 19, 2023 | |
| PLRX Pliant Therapeutics | Reiterates: Overweight | $63 | $10.60 | +494.34% | 3 | Aug 22, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Reiterates: Overweight | $54 | $21.48 | +151.40% | 3 | Aug 22, 2023 | |
| ABOS Acumen Pharmaceuticals | Reiterates: Overweight | $13 | $2.27 | +472.69% | 2 | Jul 17, 2023 | |
| IMNM Immunome | Reiterates: Overweight | $8 | $11.70 | -31.62% | 1 | Mar 20, 2023 |
Dianthus Therapeutics
Jun 27, 2024
Initiates: Overweight
Price Target: n/a
Current: $26.27
Upside: -
Jasper Therapeutics
Jun 18, 2024
Reiterates: Overweight
Price Target: n/a
Current: $22.78
Upside: -
Annexon
Jun 5, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.57
Upside: -
Alector
May 9, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.34
Upside: -
Vera Therapeutics
Jan 8, 2024
Initiates: Overweight
Price Target: n/a
Current: $34.93
Upside: -
Rezolute
Sep 19, 2023
Reiterates: Overweight
Price Target: $5
Current: $4.21
Upside: +18.76%
Pliant Therapeutics
Aug 22, 2023
Reiterates: Overweight
Price Target: $63
Current: $10.60
Upside: +494.34%
Arcturus Therapeutics Holdings
Aug 22, 2023
Reiterates: Overweight
Price Target: $54
Current: $21.48
Upside: +151.40%
Acumen Pharmaceuticals
Jul 17, 2023
Reiterates: Overweight
Price Target: $13
Current: $2.27
Upside: +472.69%
Immunome
Mar 20, 2023
Reiterates: Overweight
Price Target: $8
Current: $11.70
Upside: -31.62%